SEC Filings

Filing date Description Form Filing Group View

EFFECT

EFFECT
Other
View HTML

UPLOAD

UPLOAD
Other
View HTML

Simplified registration form

S-3
Registration Statements
View HTML

Post-effective amendment to an S-Type filing

POS AM
Registration Statements
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Form of prospectus reflecting facts events constituting substantive change from last form

424B3
Registration Statements
View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

An amendment to a SC 13D filing

SC 13D/A
Other
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
View HTML

Data provided by Kaleidoscope.

Top

External Link

You are now leaving the Jasper Therapeutics, Inc. site to a 3rd party website. Jasper Therapeutics is not responsible for 3rd party website content.